Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$315.94 - $371.96 $505,504 - $595,136
1,600 Added 320.0%
2,100 $758,000
Q2 2024

Aug 14, 2024

SELL
$324.3 - $354.67 $194,580 - $212,802
-600 Reduced 54.55%
500 $170,000
Q1 2024

May 15, 2024

BUY
$293.94 - $358.71 $176,364 - $215,226
600 Added 120.0%
1,100 $393,000
Q4 2023

Feb 14, 2024

BUY
$253.85 - $299.46 $126,925 - $149,730
500 New
500 $149,000
Q2 2023

Aug 14, 2023

SELL
$271.49 - $305.09 $81,447 - $91,526
-300 Reduced 6.0%
4,700 $1.43 Million
Q1 2023

May 15, 2023

SELL
$246.13 - $285.47 $2.58 Million - $3 Million
-10,500 Reduced 67.74%
5,000 $1.43 Million
Q3 2022

Nov 14, 2022

SELL
$189.27 - $231.83 $454,248 - $556,392
-2,400 Reduced 13.41%
15,500 $3.14 Million
Q2 2022

Aug 15, 2022

BUY
$194.09 - $276.37 $3.47 Million - $4.95 Million
17,900 New
17,900 $3.56 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.